Skip to content

call today for a free consultation

New York Personal Injury Attorneys

New York Personal Injury Attorney Blog

FDA Issues a Class One Recall on Medtronic Catheters

On November 3, 2020, the Food and Drug Administration  (FDA) issued a Class I recall, the most serious type of recall, for the Medtronic Rashkind Balloon Septostomy Catheter. The recall follows at least one reported death and two severe injuries sustained by Medtronic catheter users. The catheters are used during surgery to create an atrial…
Read More

New York Product Liability: Belviq Cancer Lawsuits Rise After FDA Orders Product Withdrawal

On February 13th, 2020, the Food and Drug Administration asked pharmaceutical distributor Eisai Inc. to voluntarily pull their weight loss drug Belviq off the market after a five-year study conducted on Belviq pointed to a link between the drug and cancer.    What is Belviq, the Popular Weight Loss Drug Recalled by the FDA?  …
Read More

Johnson & Johnson Talcum Powder Litigation Continues to Grow

A series of key decisions in multiple courts across the country have gone against Johnson & Johnson in the talcum powder litigation. Most recently, on August 5th, 2020, a New Jersey state appeals court reinstated lawsuits dismissed four years ago that claim Johnson & Johnson’s talcum powder products caused ovarian cancer. The lawsuits were revived…
Read More

FDA Requests Removal of Ranitidine (Zantac) Products From Market for Potential Carcinogen

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of the potential risk of N-nitrosodimethylamine, or NDMA, to public health. Here, the product liability attorneys at Sullivan Papain Block…
Read More

Decades of Self-Regulation in the Talc-Based Consumer Product Industry Leads to More Intensive Testing by the FDA

After decades of lax regulation of talc-based products and cosmetics, the FDA has decided to improve testing to eliminate the risk of cancerous carcinogens in consumer goods. This issue, outlined in a recent Reuters report, brings into question the validity of self-regulation in the consumer product industry, especially with the looming risk of cancer. Here,…
Read More

Free Case Evaluation

Our fee is on a contingency basis. If we don’t recover money for you, we will never charge you. If you are unable to come to any of our offices, we are happy to visit you at home or in the hospital.

*Field Required

Contact